Related Experiment Videos
[Use of the colonization index].
B Dubau1, C Triboulet, S Winnock
1Département d'anesthésie-réanimation, unité de réanimation digestive DAR III, hôpital Saint-André, 33075 Bordeaux, France.
Annales Francaises D'Anesthesie Et De Reanimation
|June 8, 2001
Summary
Monitoring the Pittet index in intensive care units can identify patients at high risk for Candida infections. This approach requires interdepartmental cooperation and increases costs and workload, impacting antifungal drug expenses.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Intensive Care Medicine
Background:
- Fungal colonization is a significant concern in intensive care units (ICUs), particularly in patients with digestive diseases.
- Early identification of patients at risk for fungal infections is crucial for timely intervention.
Purpose of the Study:
- To assess the feasibility, workload, and cost implications of monitoring fungal colonization using the Pittet index in an ICU setting.
- To evaluate the correlation between the Pittet index and the risk of Candida infection.
Main Methods:
- Retrospective analysis of 2,238 mycologic samples from 89 ICU patients over one year.
- Calculation and monitoring of the Pittet index.
- Assessment of direct pseudomycelium observation and candiduria as indicators of fungal colonization.
Main Results:
- The Pittet index effectively identified patients at high risk for Candida infection.
- Monitoring the Pittet index necessitated strong collaboration between ICU and mycology labs, increasing costs and workload.
- Treatment initiation based on a colonization index ≥ 0.5 with clinical signs led to increased antifungal drug expenditure.
- Direct pseudomycelium and candiduria correlated significantly with fungal colonization.
Conclusions:
- The Pittet index is a valuable tool for identifying high-risk patients for Candida infections in ICUs.
- Implementing Pittet index monitoring requires significant resources and interdepartmental coordination.
- Further studies are needed to evaluate the clinical benefits and cost-effectiveness of this monitoring strategy.